tradingkey.logo

Insulet Corp

PODD
View Detailed Chart

288.400USD

-9.870-3.31%
Close 07/31, 16:00ETQuotes delayed by 15 min
20.29BMarket Cap
50.45P/E TTM

Insulet Corp

288.400

-9.870-3.31%
Intraday
1m
30m
1h
D
W
M
D

Today

-3.31%

5 Days

+0.60%

1 Month

-8.21%

6 Months

+2.99%

Year to Date

+10.47%

1 Year

+48.82%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 26 analysts
BUY
Current Rating
338.930
Target Price
13.63%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

117
Total
6
Median
8
Average
Company name
Ratings
Analysts
Insulet Corp
PODD
26
Medtronic PLC
MDT
34
Stryker Corp
SYK
33
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
Dexcom Inc
DXCM
28
1
2
3
...
24

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Sell
Sell(8)
Neutral(3)
Buy(2)
Indicators
Sell(4)
Neutral(3)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
1.955
Neutral
RSI(14)
43.973
Neutral
STOCH(KDJ)(9,3,3)
61.584
Sell
ATR(14)
5.439
Low Volatility
CCI(14)
51.283
Neutral
Williams %R
59.759
Sell
TRIX(12,20)
-0.229
Sell
StochRSI(14)
0.000
Sell
Moving Average
Sell(4)
Neutral(0)
Buy(2)
Indicators
Value
Direction
MA5
292.130
Sell
MA10
288.466
Sell
MA20
291.041
Sell
MA50
304.098
Sell
MA100
284.622
Buy
MA200
274.127
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Insulet Corporation is a medical device company. It is primarily engaged in the development, manufacture and sale of its continuous insulin delivery systems for people with insulin-dependent diabetes. The Omnipod System includes the Omnipod 5 Automated Insulin Delivery System (Omnipod 5), the Omnipod DASH Insulin Management System, and the Omnipod Insulin Management System. The Omnipod platform offers continuous insulin delivery that provides various benefits of insulin pump therapy in a way without the need for external tubing required with conventional pumps. The small, lightweight, self-adhesive disposable tubeless Omnipod device (Pod), can be worn in multiple locations, including the abdomen, hip, back of upper arm, upper thigh, or lower back, and delivers insulin into the body through a small flexible tube. It also produces pods for Amgen for use in the Neulasta Onpro kit, a delivery system for Amgen’s Neulasta to help reduce the risk of infection after intense chemotherapy.
Ticker SymbolPODD
CompanyInsulet Corp
CEOMs. Ashley Mcevoy
Websitehttps://www.omnipod.com
KeyAI